GlassScriptPhysician profile
Michael Bruce Cannon
NPI 1750376026
$17,515.59
in general payments reported to CMS, 2019-2025
20 companies · $15K in 2025
The $15K reported for 2025 was more than what 92% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2020: $736 · 2021: $431 · 2022: $386 · 2023: $240 · 2024: $848 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $10K · Travel and Lodging: $3,406 · Food and Beverage: $2,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $10,000.00 |
| Travel and Lodging | $3,406.42 |
| Food and Beverage | $2,374.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,760.89 | 2024-2025 | |
| Atricure, INC. | $2,384.81 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atricure Cryoice Cryosphere Cryoablation System, Synergy Ablation System |
| Abbott Laboratories | $684.89 | 2020-2021 | |
| Abiomed | $619.06 | 2023-2025 | Impella |
| Edwards Lifesciences Corporation | $365.38 | 2020-2022 | |
| Medtronic, INC. | $258.72 | 2022-2025 | Micra, Aurora Ev-Icd Mri Surescan, Corevalve Evolut R |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $146.05 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $47.65 | 2024-2025 | Winrevair, Verquvo, Capvaxive |
| Philips North America LLC | $41.29 | 2025 | Extended Holter |
| Acera Surgical, INC. | $37.73 | 2021 | |
| Medtronic Vascular, INC. | $22.10 | 2019 | |
| Lilly USA, LLC | $19.66 | 2019 | |
| Artivion, INC. | $18.89 | 2019 | |
| Esperion Therapeutics, INC. | $18.06 | 2024 | Nexletol |
| Baxter Healthcare | $18.03 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $16.34 | 2024 | Ozempic |
| Pacira Pharmaceuticals Incorporated | $15.65 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.35 | 2025 | Jardiance |
| Chiesi USA, INC. | $13.97 | 2025 | Cleviprex |
| Getinge USA Sales, LLC | $11.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cannon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.